Six COVID-19 vaccine candidates, including three from China, have entered phase-3 trials, a senior World Health Organization (WHO) official said on Thursday.
The three Chinese candidates are from Sinovac, Wuhan Institute of Biological Products/Sinopharm and Beijing Institute of Biological Products/Sinopharm, said Michael Ryan, executive director of the WHO Health Emergencies Program, at a virtual briefing.
The other three are made by the University of Oxford/AstraZeneca, Moderna/NIAID and BioNTech/Fosun Pharma/Pfizer, he added.
The vaccines will be put into the general population for the first time in phase 3, after previous trials have focused on safety, immunogenicity and immune response in a small number of humans, said the WHO official. The phase-3 trial will test whether the vaccines can "protect large numbers of people over a prolonged period of time."
However, "phase-3 doesn't mean nearly there," he said, as "there is no guarantee that any of these six will give us the answer."
In total, 165 vaccine candidates have started some forms of trials, and 26 of them in clinical trials, according to WHO records.
Distribution of pharma product needs to be accredited with GDP from MOH. How in hell the PPE distributor like titijaya can become vaccine hub. For ASEAN some more. Aiyo if wanna goreng also at least do some research before you get burnnnn.
James89 Distribution of pharma product needs to be accredited with GDP from MOH. How in hell the PPE distributor like titijaya can become vaccine hub. For ASEAN some more. Aiyo if wanna goreng also at least do some research before you get burnnnn. 07/08/2020 9:51 PM
Titijaya cant make vaccine. But the China partnership Sinopharma ca n make vaccine. Titijaya Will leverage of sinopharma for distribution of vaccine in malaysia
pang72 distribution of PPE is not same as pharma products as they need to have GDP certificate issued by gov. How Titijaya as property company got this accreditation pang. Wake up!
There is no way property company like titijaya will passed the GMP test without having the actual pharma factory. Dpharma has good track record for “fill and finish” for its insulin product supply from biocon in huge volume to gov. And theres no time to wait for new plant whatsoever since the vaccine will come out in near future. Wake up people! Dont let ur fingers burn!!
Hwgb invest in polio vaccine not covid vaccine. Thats why it was so low 1m only. Polio vaccine has been ongoing since 90s. Polio vaccine can prevent covid only not cure covid.
The partnership with sinipharm is real but to get the vaccine contract is not realistic.
This counter sure can limit up but the last one to enter will burned.
KUALA LUMPUR (April 29): Titijaya Land Bhd has inked a five-year agreement with a Chinese state-owned medical equipment manufacturer to develop a business that will be involved in the trading and distribution of medical and hospital equipment, as well as medical industry-related real estate.
In a bourse filing, the group said its wholly-owned Titijaya Resources Sdn Bhd (TRSB) had inked the strategic collaboration agreement with Sinopharm Medical Equipment QuanZhou Co. Ltd (SMEQ), which is part of Sinopharm China National Medical Device Company, whose holding company is China National Pharmaceutical Group Corp (Sinopharm Group).
"Sinopharm Group is a large healthcare group directly under the State-owned Assets Supervision and Administration Commission (SASAC) of the State Council, with a full chain in the industry covering R&D (research and development), manufacturing, logistics and distribution, retail chains, healthcare, engineering services, exhibitions and conferences, international business and financial services," said Titijaya.
The main, immediate focus of the collaboration will be the supply of equipment such as personal protection equipment (PPE), RT-PCR (real-time reverse transcription polymerase chain reaction) test kits, rapid test kits, mobile test labs and other necessary equipment needed to combat Covid-19.
Under the agreement, Titijaya said TRSB and SMEQ will collaborate to develop the business by leveraging on the supply and value chain of Sinopharm Group and SMEQ in China, as well as the networks of TRSB and Sinopharm Group.
“For other businesses of Sinopharm Group not within the scope of business of SMEQ, SMEQ will assist TRSB to develop such scope of business by coordinating with Sinopharm Group to accommodate the demands of TRSB,” Titijaya said.
TRSB, meanwhile, will be responsible to provide infrastructure, land and facilities for medical industry operators recommended by Sinopharm Group or SMEQ.
The agreement can be renewed for another five-year term, subject to agreement by both parties.
Titijaya shares closed unchanged at 26 sen apiece today, giving it a market capitalisation of RM352.37 million. It saw 304,100 shares changing hands.
Old news but this will give you the idea on how long it takes to build the facility needed to conduct fill and finish (ie vaccine) of the terminal sterile production line.
This agreement is for PPE la not vaccine hub. And this agreement has nothing to say about vaccine at all. The GMP test to distribute vaccine is the key issues here thats why it was bring up in the parliment. Otherwise everyone will be the distributer for vaccine.
Sinopharm itself is a pharma company thats why they can distribute the vaccine wherever they like. Unlike titjaya is property company. To be the distributer for drug is a long way to go.
TRSB, meanwhile, will be responsible to provide infrastructure, land and facilities for medical industry operators recommended by Sinopharm Group or SMEQ.
The main, immediate focus of the collaboration will be the supply of equipment such as personal protection equipment (PPE), RT-PCR (real-time reverse transcription polymerase chain reaction) test kits, rapid test kits, mobile test labs and other necessary equipment needed to combat Covid-19.
Nothing on vaccine at all. The news came out in april and they already at stage 3 for vaccine. Now is august already why no vaccine hub announcement till now. You think vaccine hub is one day construction aa?
pang72 TRSB, meanwhile, will be responsible to provide infrastructure, land and facilities for medical industry operators recommended by Sinopharm Group or SMEQ.
THIS IS BIO PHARMA RELATED HUB!
There should be at least announcement on the land and infrastructure by now dont u think?
I like the partnership with giant company sinopharma..
It is like if I can see any partnership of SKP to build plant for Apple in Malaysia.. I know to build a plant need 1, 2 years but I will sialang today but not the plant completion.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
pang72
51,982 posts
Posted by pang72 > 2020-08-07 18:49 | Report Abuse
I can't agree hwgt can limit up to 1.20 with fake collaboration on vaccine..
However, sinopharma top notch China pharma company partner with Titijaya only up 14c to 46c closing.
I am absolutely can not convince...
So, we sapu lorry by lorry and wait for next week limit up when people realise who is China Giant Pharma Co.... Sinopharma!